Carcinoma: all 6,718 studies
Page 46 of 68. Open to participants first (1,141), then studies with results posted, then the rest; newest registration first within each.
- Bioimmunoradiotherapy (Cetuximab/RT/Avelumab)CompletedNCT02938273Phase 1
- Bronchoscopy With Bronchoalveolar Lavage in Identifying Biomarkers of Response to Immune Checkpoint Inhibitors in Patients With Non-small Cell or Small Cell Lung CancerTerminatedNCT02937402Not applicable
- Bariatric Embolization of Arteries in Obese Patients With HCC to Allow Salvage Liver TransplantationSuspendedNCT02935478Not applicable
- Minocycline Attenuate Postoperative Cognitive Dysfunction and DeliriumStatus unknownNCT02928692Phase 3
- Healthcare Cost and Resource Utilization Related to Metastatic Renal Cell Carcinoma Treatment With Intravenous and Oral AgentsWithdrawnNCT02928263
- Yang Yin Fu Zheng Therapy in HBV Associated Hepatocellular CarcinomaCompletedNCT02927626Early Phase 1
- Robot-Assisted Laparoscopic Radio Frequency Ablation Assisted Enucleation of Renal Cell Carcinoma With T1a StageStatus unknownNCT02924597Not applicable
- Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinoma PatientsStatus unknownNCT02923557Phase 2
- Comparing Re-TACE Versus SABR for Post-prior-TACE Incompletely Regressed HCC: a Randomized Controlled Trial (TASABR)Status unknownNCT02921139Not applicable
- Combined Alternating Sunitinib and Bevacizumab (Avastin®) in Advanced Renal Cell Carcinoma (CASA)Status unknownNCT02919371Phase 1/2
- Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Renal Cell CarcinomaCompletedNCT02917772Phase 2
- Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy Concurrent With Chemotherapy for Esophageal Squamous Cell CarcinomaCompletedNCT02916511Phase 2
- The Clinical Study of the Poorly Differentiated Head and Neck Squamous Cell CarcinomaStatus unknownNCT02916368
- A Trial of Neoadjuvant Chemotherapy for Stage II, III Esophageal Squamous Cell CarcinomaStatus unknownNCT02915965Phase 2
- The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCCStatus unknownNCT02915432Phase 1/2
- S-1 IMRT Versus S-1 and Cisplatin Concurrent IMRT in Inoperable Esophageal Squamous Cell CarcinomaStatus unknownNCT02913066Phase 2
- Long-term Outcomes of Superficial Esophageal Squamous Cell CarcinomaStatus unknownNCT02908204
- Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT02907710Phase 3
- Galunisertib (LY2157299) Plus Stereotactic Body Radiotherapy (SBRT) in Advanced Hepatocellular Carcinoma (HCC)CompletedNCT02906397Phase 1
- Glypican 3-specific Chimeric Antigen Receptor Expressing T Cells for Hepatocellular Carcinoma (GLYCAR)CompletedNCT02905188Phase 1
- Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of BergamoCompletedNCT02902822Not applicable
- FDGal PET/CT to Detect Hepatocellular CarcinomaWithdrawnNCT02899325
- A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder CancerCompletedNCT02897765Phase 1
- A Phase II Study of HMPL-504 in Lung Sarcomatoid Carcinoma and Other Non-small Cell Lung CancerStatus unknownNCT02897479Phase 2
- Yoga in Improving Quality of Life in Patients With Non-small Cell Lung Cancer Undergoing TreatmentTerminatedNCT02895503Not applicable
- Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis FungoidesTerminatedNCT02890368Phase 1
- A Study of Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid TumorsStatus unknownNCT02886897Phase 1/2
- Enzalutamide Before Surgery in Treating Patients With Kidney CancerTerminatedNCT02885649Early Phase 1
- Study of Pembrolizumab as First Line Therapy in Patients With Unresectable Squamous Cell Carcinoma of the SkinCompletedNCT02883556Phase 2
- Chidamide for Advanced Cephalic and Cervical Adenocystic Carcinoma: Evaluation of Efficiency and SafetyStatus unknownNCT02883374Phase 2
- Zirconium-89-girentuximab PET/CT Imaging in Renal Cell CarcinomaCompletedNCT02883153Phase 2/3
- Preoperative Administration of Olaparib With Cisplatin or With Durvalumab or Alone or no Tratment in Patients Who Are Candidates for Surgery of Carcinoma of the Head and Neck.CompletedNCT02882308Phase 2
- Trametinib in Treating Patients With Progressive Metastatic Hormone-Resistant Prostate CancerActive, not recruitingNCT02881242Phase 2
- Paclitaxel and Nortriptyline Hydrochloride in Treating Patients With Relapsed Small Cell CarcinomaCompletedNCT02881125Phase 1
- Dose-finding, Safety and Efficacy Study of Radium-223 Dichloride (XOFIGO) in RCC Patients With Bone Metastases. (EIFFEL)Status unknownNCT02880943Phase 1/2
- Hepatocellular Carcinoma and Rheumatoid ArthritisCompletedNCT02880306
- Serum Squamous Cell Carcinoma Antigen Level and Tumor Volume in Head and Neck CancerCompletedNCT02879968
- A Phase II Trial of S-1 as Maintenance Treatment After Gemcitabine Plus Cisplatin Regimen Chemotherapy in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma.Status unknownNCT02878889Phase 2
- DCE-MRI for Assessment of Response to TACE of HCCCompletedNCT02878109
- Anti-GPC3 CAR T for Recurrent or Refractory Lung Squamous Cell CarcinomaStatus unknownNCT02876978Phase 1
- Neoadjuvant Chemotherapy Versus Surgery Alone in Patients With High-Grade UTUCCompletedNCT02876861Phase 2
- Safety and Efficacy Study of GL-0817 (With Cyclophosphamide) for the Prevention of Recurrence of Squamous Cell Carcinoma of the Oral CavityCompletedNCT02873819Phase 2
- Immunotherapy in High-risk Ductal Carcinoma in Situ (DCIS)Active, not recruitingNCT02872025Early Phase 1
- Clinical Trial on Acupuncture Adjuvant Treatment in the Pain After the Surgery of Gastrointestinal CarcinomaCompletedNCT02871999Not applicable
- Two Cycles Versus Three Cyclle of CCRT for Low Risk Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT02871518Phase 2
- Chemoembolization of Non-resectable Non-metastatic Hepatocellular Carcinoma Using Embolization MicrospheresCompletedNCT02870010Phase 1
- PD-1 Knockout Engineered T Cells for Metastatic Renal Cell Carcinoma.WithdrawnNCT02867332Phase 1
- Sorafenib Treatment in Patients With Hepatocellular Carcinoma With Microvascular Invasion After Radical ResectionTerminatedNCT02867280Phase 3
- Safety of Intraperitoneal (IP) OXAliplatin (OXA) in Association With Systemic FOLFIRI Bevacizumab Chemotherapy in Patients With Peritoneal CarcinosisStatus unknownNCT02866903Phase 1/2
- Study Of Nintedanib Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or EndometriumStatus unknownNCT02866370Phase 2
- Safety and Preliminary Efficacy of SBRT in Patients With Metastatic RCC Treated With Targeted or IO TherapyCompletedNCT02864615Not applicable
- Liposomal Paclitaxel Combined Nedaplatin in Treatment of Advanced or Recurrent Esophageal CarcinomaCompletedNCT02861690Phase 2
- Lenvatinib in Recurrent and/or Metastatic Adenoid Cystic Carcinomas of the Salivary Glands: ACC-LEN14CompletedNCT02860936Phase 2
- Comparison of Response and Recurrence Rates Following Percutaneous Microwave Coagulation Therapy Versus Percutaneous Radiofrequency AblationCompletedNCT02859753Not applicable
- Clinical Trial of Sipjeondaebo-tang on Fatigue of Breast Cancer PatientsStatus unknownNCT02858856Not applicable
- Safety and Efficacy of "Immuncell-LC" in TACE TherapyCompletedNCT02856815Phase 2
- HAIC Plus Sorafenib Versus TACE Plus Sorafenibfor Advanced HCCCompletedNCT02856126Phase 3
- Randomized, Open-label Economic and Medical Study on the Lymph Node Management of Squamous Cell Carcinoma of the Oral Cavity and Oropharynx Tumor Stage 1 or 2, Nodes 0 (T1-T2 N0) OperableCompletedNCT02855723Not applicable
- A Study of MG4101 (Allogeneic Natural Killer Cell) for Intermediate-stage of Hepatocellular CarcinomaCompletedNCT02854839Phase 2
- Dietary Nitrate on Salivary Flow for Nasopharyngeal Carcinoma PatientsStatus unknownNCT02854410Not applicable
- Ablative tReatment of Inoperable REnal Cell Carcinoma Using STereotactic Body Radiotherapy (ARREST-study)TerminatedNCT02853162Phase 2
- One-step Nucleic Acid Amplification for Detecting Lymph Node Metastasis of Head and Neck Squamous Cell CarcinomaCompletedNCT02852343
- Pair Production PET Imaging to Detect Particle Distribution in Patients Undergoing Yttrium-90 RadioembolizationCompletedNCT02848638
- Dynamic Contrast Enhanced HCC SABR Liver StudyStatus unknownNCT02847767Not applicable
- Multimetabolic 18F-Fluorodeoxyglucose (FDG) and 18F-Fluorocholine (FCH) Positron Emission Tomography (PET) as an Early Predictive Factor of Overall Survival in Patients With Advanced Hepatocellular Carcinoma Treated With SorafenibTerminatedNCT02847468Not applicable
- Cost-utility of Two Strategies of Perineal Reconstruction After Abdominoperineal Resection for Anorectal CarcinomaStatus unknownNCT02841293Not applicable
- Pilot Study on Intra-abdominal Photodynamic Diagnosis in Peritoneal CarcinosisStatus unknownNCT02840331Phase 3
- CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid TumorStatus unknownNCT02839954Phase 1/2
- A Dose Escalation, Safety and Activity Study of CDX-014 in Patients With Renal Cell Carcinoma and Ovarian Clear Cell CarcinomaTerminatedNCT02837991Phase 1
- Study of Nintedanib Plus Bevacizumab in Advanced Solid TumorsCompletedNCT02835833Phase 1
- Correlation Between Sorafenib Plasma Concentrations, Toxicity and Disease Control Rate in Patients Treated by Sorafenib for Hepatocellular CarcinomaCompletedNCT02834546
- Trial of Intraperitoneal (IP) Oxaliplatin in Combination With Intravenous FOLFIRICompletedNCT02833753Phase 1
- Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerWithdrawnNCT02833506Phase 1
- Post Sustained Virological Response (SVR) Hepatocellular Carcinoma (HCC) ScreeningCompletedNCT02833298Not applicable
- RFA for Small HCC With No-touch Technique Using Octopus ElectrodeCompletedNCT02832882Not applicable
- Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine TumorWithdrawnNCT02831179Phase 1
- No-touch RFA Versus Traditional RFA for Small Hepatocellular CarcinomaStatus unknownNCT02830737Not applicable
- Study Comparing the Role of the Laparoscopy Surgical Staging in the Peritoneal Carcinomatosis to Laparotomic ApproachStatus unknownNCT02829788
- Assessment of the Clinic-pathological Correlation of Basal Cell CarcinomaCompletedNCT02825511
- Rebastinib Plus Antitubulin Therapy With Paclitaxel or Eribulin in Metastatic Breast CancerTerminatedNCT02824575Phase 1
- Copanlisib in Association With Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinomas Harboring a PI3KCA Mutation/Amplification and/or a PTEN LossTerminatedNCT02822482Phase 1/2
- Chemoembolization for Hepatocellular CarcinomaTerminatedNCT02821533Phase 2
- MEDI4736 Combinations in Metastatic Renal Cell CarcinomaCompletedNCT02819596Phase 2
- I-MVAC +/- Panitumumab as First-line Treatment of Advanced Urothelial Carcinoma Without H-Ras Nor K-Ras MutationsCompletedNCT02818725Phase 3
- Follow-up Strategy of Chronic Hepatitis B for Early Detection and Diagnosis of Hepatocellular Carcinoma: A Randomized Control TrialStatus unknownNCT02817685
- The Safety and Maximum Tolerated Dose of Axitinib in Combination With Radiotherapy for HCCCompletedNCT02814461Phase 1
- Study of Folfox4 Chemotherapy Regimen to Prevent Early Postoperative Recurrence for HCC-PVTT PatientsStatus unknownNCT02813096Not applicable
- Neoadjuvant CCRT With/Without Bevacizumab for Locally Advanced ESCCStatus unknownNCT02812641Phase 2
- A Study of Anlotinib in Patients With Hepatocellular CarcinomaStatus unknownNCT02809534Phase 2
- Abiraterone Acetate, Niclosamide, and Prednisone in Treating Patients With Hormone-Resistant Prostate CancerActive, not recruitingNCT02807805Phase 2
- ME-344 in Early HER2-negative Breast Cancer With Antiangiogenic-induced Mitochondrial MetabolismCompletedNCT02806817Early Phase 1
- RFA for Small HCC With No-touch Technique and Dual Cooled-Wet ElectrodeStatus unknownNCT02806076Not applicable
- Radical Treatment of Synchronous Oligometastatic Non-Small Cell Lung CarcinomaCompletedNCT02805530Not applicable
- Dynamic Changes of Circulating Tumor DNA in Late Stage NSCLC PatientsStatus unknownNCT02804100
- Hyperthermic Intraperitoneal Chemotherapy (HIPEC) : Predictive Marker and MechanismTerminatedNCT02803515Not applicable
- Carbon Ion Radiotherapy for the Treatment of Chinese Hepatocellular CarcinomaTerminatedNCT02802124Not applicable
- Trial Evaluating Carbon Ion Radiotherapy With Concurrent Chemotherapy for Locally Recurrent Nasopharyngeal CarcinomaTerminatedNCT02801487Phase 1/2
- 5 Years Follow-up With Adjuvant Therapy for Women With Breast Invasive CarcinomaCompletedNCT02791750
- Nedaplatin Combined With Gemcitabine in the Treatment of Recurrent and/or Metastatic Nasopharyngeal Carcinoma : a Single Arm and Phase Ⅱ Clinical TrailTerminatedNCT02789189Phase 2
- Lenvatinib and Weekly Paclitaxel for Patients With Recurrent Endometrial or Ovarian CancerCompletedNCT02788708Phase 1